Skip to main content
. 2017 Aug 4;28(11):3155–3165. doi: 10.1681/ASN.2016121344

Table 1.

Risk factors for the development of hyperkalemia

Clinical Risk Factor Medication Exposure
Male sex Potassium supplements
Non-black Penicillin G
DM Digoxin
CVD NSAIDs
CHF ACEi/ARBs
AKI MRAs
CKD β-adrenergic blockers
Acidosis Heparin
Urinary obstruction Amiloride, Triamterene
Trimethoprim, Pentamidine

DM, diabetes mellitus; CVD, cardiovascular disease; NSAIDs, nonsteroidal anti-inflammatory drugs; CHF, congestive heart failure; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blockade.